Thomas Schmidt joined Evaxion in 2024, bringing more than 29 years of financial management experience from across different industries, with more than 25 years of these being based in the life science industry, including roles as country Managing Director and Chief Financial Officer in Roche and Group CFO in Ambu.
Mr. Schmidt holds a Master of Science in Business Economics and Auditing from Copenhagen Business School and has undergone training and preparation for State Authorized Public Accountant (CPA) exam.
